250 related articles for article (PubMed ID: 9871334)
21. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
22. In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.
Murray BE; Moellering RC
Ann Intern Med; 1982 Feb; 96(2):176-80. PubMed ID: 7036812
[TBL] [Abstract][Full Text] [Related]
23. Therapy of Klebsiella pneumoniae septicaemia in neutropenic rats.
Magliulo E; Piantieri G; Cafarelli A; Cruciani M
Pharmatherapeutica; 1982; 3(2):114-8. PubMed ID: 7048337
[TBL] [Abstract][Full Text] [Related]
24. [Enterobacteria isolated in hospitals. Comparison of the bacteriostatic and bactericidal activity of amikacin, gentamicin and tobramycin].
Kazmierczak A; Gailliard MC; Pothier P; Siebor E; Portier H
Nouv Presse Med; 1979 Oct; 8(42):3399-402. PubMed ID: 537884
[No Abstract] [Full Text] [Related]
25. [Sensitivity of 1041 strains of bacteria obtained from an intensive care unit with regard to aminoglycosides].
Beney E; Robert D; Tigaud S; Blanc PL; Vincent P
Nouv Presse Med; 1982 Nov; 11(46):3396-9. PubMed ID: 7155847
[TBL] [Abstract][Full Text] [Related]
26. The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Máthé A; Szabó D; Anderlik P; Rozgonyi F; Nagy K
Diagn Microbiol Infect Dis; 2007 May; 58(1):105-10. PubMed ID: 17300908
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
[TBL] [Abstract][Full Text] [Related]
28. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
29. [Post-antibiotic effect of three aminoglycosides against Klebsiella pneumoniae].
de Montclos M; Guinet M; Chapuis C; Flandrois JP
Pathol Biol (Paris); 1994 May; 42(5):419-24. PubMed ID: 7824306
[TBL] [Abstract][Full Text] [Related]
30. Hydrophobicity and outer membrane proteins of Shigella dysenteriae type 1 after treatment with subinhibitory concentrations of aminoglycosides.
Hostacká A; Karelová E
Folia Microbiol (Praha); 1997; 42(6):565-8. PubMed ID: 9438357
[TBL] [Abstract][Full Text] [Related]
31. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic susceptibility, serum response and surface properties of Klebsiella species.
Hostacká A; Klokocníková
Microbios; 2001; 104(408):115-24. PubMed ID: 11297012
[TBL] [Abstract][Full Text] [Related]
33. Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.
Minshew BH; Pollock HM; Schoenknecht FD; Sherris JC
Antimicrob Agents Chemother; 1977 Dec; 12(6):688-96. PubMed ID: 412464
[TBL] [Abstract][Full Text] [Related]
34. Post-antibiotic effect of isepamicin compared to that of other aminoglycosides.
Minguez F; Agra M; Lurueña S; Ramos C; Prieto J
Drugs Exp Clin Res; 1990; 16(5):231-5. PubMed ID: 2078989
[TBL] [Abstract][Full Text] [Related]
35. Postantibiotic effect of aminoglycosides on staphylococci.
Isaksson B; Maller R; Nilsson LE; Nilsson M
J Antimicrob Chemother; 1993 Aug; 32(2):215-22. PubMed ID: 8226423
[TBL] [Abstract][Full Text] [Related]
36. Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics.
Sekowska A; Janicka G; Kłyszejko C; Wojda M; Wróblewski M; Szymankiewicz M
Med Sci Monit; 2002 Mar; 8(3):BR100-4. PubMed ID: 11889457
[TBL] [Abstract][Full Text] [Related]
37. [In vitro demonstration of a true post-beta-lactamases inhibitor effect (PLIE) of clavulanic acid on Klebsiella pneumoniae and Haemophilus influenzae].
Murbach V; Dhoyen N; Linger L; Monteil H; Jehl F
Pathol Biol (Paris); 1999 May; 47(5):462-8. PubMed ID: 10418019
[TBL] [Abstract][Full Text] [Related]
38. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
Agence française de sécurité sanitaire des produits de santé
Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
[No Abstract] [Full Text] [Related]
39. Alteration of effectiveness of antibiotics by anaerobiosis.
Verklin RM; Mandell GL
J Lab Clin Med; 1977 Jan; 89(1):65-71. PubMed ID: 318675
[TBL] [Abstract][Full Text] [Related]
40. Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains.
Majtán V; Majtánová L
Folia Microbiol (Praha); 1997; 42(4):327-32. PubMed ID: 9449780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
